Loading clinical trials...
Loading clinical trials...
Phase 1 First in Human Dose Escalation and Safety Study of Topical ENS-002 for Atopic Dermatitis in Adults
Conditions
Interventions
ENS-002
Locations
3
United States
Encore Medical Research
Hollywood, Florida, United States
Northeast Dermatology Associates
Beverly, Massachusetts, United States
Derm Research
Austin, Texas, United States
Start Date
September 18, 2024
Primary Completion Date
August 4, 2025
Completion Date
August 4, 2025
Last Updated
August 14, 2025
NCT07262983
NCT06389136
NCT06342713
NCT07223697
NCT07290803
NCT07265479
Lead Sponsor
Concerto Biosciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions